Skip to main content

Find Clinical Trials

Home
Conditions
Phosphorus Metabolism Disorders

Clinical trial condition

Phosphorus Metabolism Disorders

Explore clinical trials studying Phosphorus Metabolism Disorders. Study availability and eligibility vary by location and protocol.

186 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Phosphorus Metabolism Disorders trial results

Completed

Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis

NCT00853242

Conditions: Chronic Disease, Disease Attributes, Female Urogenital Diseases, +14 more
Locations: Alexander City, Alabama, United States

Birmingham, Alabama, United States

Hot Springs, Arkansas, United States

Bakersfield, California, United States

View all 53 locations

View Trial Details

Completed

Long-term Study in Chronic Kidney Disease (Extension From Study 14817)

NCT01187628

Conditions: Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations: Anjo, Aichi-ken, Japan

Nagoya, Aichi-ken, Japan

Nagoya, Aichi-ken, Japan

Nagoya, Aichi-ken, Japan

View all 40 locations

View Trial Details

Completed

Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia

NCT01857024

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +15 more
Locations: Graz, Austria

Linz, Austria

Aalborg, Denmark

Cabestany, France

View all 26 locations

View Trial Details

Completed

An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis

NCT00681941

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +14 more
Locations: Nephrology Department, Princess Alexandra Hospital Wooloongabba, Queensland, Australia

Renal Unit, The Queen Elizabeth Hospital Woodville, South Australia, Australia

Renal Research Unit, Launceston General Hospital Launceston, Tasmania, Australia

The Royal Melbourne Hospital, Department of Nephrology Parkville, Victoria, Australia

View all 25 locations

View Trial Details

Completed

Effect of Restriction of Foods Containing Phosphorus Additives

NCT01965379

Conditions: Chronic Disease, Disease Attributes, End-stage Renal Disease, +15 more
Locations: Faculdade de Ciências Médicas da Santa Casa de São Paulo São Paulo, Brazil

View Trial Details

Completed

Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering)

NCT01424787

Conditions: Chronic Disease, Disease Attributes, ESRD, +16 more
Locations: Regionshospitalet Holstebro Holstebro, Denmark

Nykøbing Falster Sygehus Nykøbing Mors, Nykobing, Denmark

Roskilde Sygehus Roskilde, Denmark

Viborg Sygehus Viborg, Denmark

View all 24 locations

View Trial Details

Completed

A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis

NCT01191255

Conditions: Chronic Disease, Disease Attributes, Female Urogenital Diseases, +15 more
Locations: Southwest Clinical Research Institute, LLC Tempe, Arizona, United States

Tower Nephrology Medical Group Los Angeles, California, United States

Veterans Administration Greater Los Angeles Healthcare System, West Los Angeles Los Angeles, California, United States

Apex Research of Riverside Riverside, California, United States

View all 56 locations

View Trial Details

Completed

Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

NCT00967993

Conditions: Chronic Disease, Diabetes Mellitus, Disease Attributes, +19 more
Locations: Barzilai Medical Center Ben-Gurion University Ashkelon, Israel

Hadassah University Hospital-Ein Kerem Jerusalem, Israel

Assaf Haraofeh Medical Center Ẕerifin, Israel

View Trial Details

Completed

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

NCT01074125

Conditions: Chronic Disease, Disease Attributes, End-stage Renal Disease, +15 more
Locations: Western Nephrology Westminster, Colorado, United States

Pines Clinical Research, Inc. Pembroke Pines, Florida, United States

Kidney Care Associates, LLC Augusta, Georgia, United States

Circle Medical Management Chicago, Illinois, United States

View all 16 locations

View Trial Details

Completed

A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia

NCT01852682

Conditions: Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +2 more
Locations: Tokyo and Other Japanese City, Japan

View Trial Details